Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies

Abby E. Rudolph, Natalie D. Crawford, Danielle C. Ompad, Ebele O. Benjamin, Rachel J. Stern, Crystal M. Fuller

Research output: Contribution to journalArticle

Abstract

Objective: To describe injection drug users (IDUs) who access syringes through different outlets to help inform the prevention needs of IDUs who underuse safe syringe sources in New York City (NYC), where syringe availability is high compared with other U.S. cities. Design: Cross sectional. Setting: NYC, 2005-2007. Participants: 285 IDUs. Intervention: Participants were recruited using random street-intercept sampling in 36 socioeconomically disadvantaged neighborhoods. Main outcome measures: IDUs using syringe exchange programs (SEPs), pharmacies, or other outlets as a primary syringe source were compared based on sociodemographic characteristics, injection practices, and medical service use. Results: Chi-square tests and polytomous logistic regression were used to compare IDUs with different self-reported primary syringe sources used in the 6 months preceding study entry. Compared with IDUs using other syringe sources, those primarily using SEPs were less likely to be black (adjusted odds ratio 0.26 [95% CI 0.11-0.57]), more likely to inject daily (3.32 [1.58-6.98]), and more likely to inject with a new syringe (2.68 [1.30-5.54]). Compared with IDUs using other syringe sources, those primarily using pharmacies were less likely to be black (0.39 [0.17-0.90]). Conclusion: These data suggest that pharmacies and SEPs may be reaching different populations of IDUs and highlight a subpopulation of highly marginalized IDUs (i.e., black race, infrequent injectors) who are underusing safe syringe sources in NYC. Targeted interventions are needed to reduce racial disparities and increase use of safe syringe outlets.

Original languageEnglish (US)
Pages (from-to)140-147
Number of pages8
JournalJournal of the American Pharmacists Association
Volume50
Issue number2
DOIs
StatePublished - 2010

Fingerprint

Needle-Exchange Programs
Syringes
Pharmacies
Drug Users
HIV
Injections
Pharmaceutical Preparations
Vulnerable Populations
Chi-Square Distribution
Logistic Models

Keywords

  • Human immunodeficiency virus
  • Pharmacy services
  • Race
  • Syringe access
  • Syringe exchange programs

ASJC Scopus subject areas

  • Pharmacy
  • Pharmacology
  • Pharmacology (nursing)
  • Medicine(all)

Cite this

Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies. / Rudolph, Abby E.; Crawford, Natalie D.; Ompad, Danielle C.; Benjamin, Ebele O.; Stern, Rachel J.; Fuller, Crystal M.

In: Journal of the American Pharmacists Association, Vol. 50, No. 2, 2010, p. 140-147.

Research output: Contribution to journalArticle

@article{7fe84c08cf9641c2ab0932441fef0f97,
title = "Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies",
abstract = "Objective: To describe injection drug users (IDUs) who access syringes through different outlets to help inform the prevention needs of IDUs who underuse safe syringe sources in New York City (NYC), where syringe availability is high compared with other U.S. cities. Design: Cross sectional. Setting: NYC, 2005-2007. Participants: 285 IDUs. Intervention: Participants were recruited using random street-intercept sampling in 36 socioeconomically disadvantaged neighborhoods. Main outcome measures: IDUs using syringe exchange programs (SEPs), pharmacies, or other outlets as a primary syringe source were compared based on sociodemographic characteristics, injection practices, and medical service use. Results: Chi-square tests and polytomous logistic regression were used to compare IDUs with different self-reported primary syringe sources used in the 6 months preceding study entry. Compared with IDUs using other syringe sources, those primarily using SEPs were less likely to be black (adjusted odds ratio 0.26 [95{\%} CI 0.11-0.57]), more likely to inject daily (3.32 [1.58-6.98]), and more likely to inject with a new syringe (2.68 [1.30-5.54]). Compared with IDUs using other syringe sources, those primarily using pharmacies were less likely to be black (0.39 [0.17-0.90]). Conclusion: These data suggest that pharmacies and SEPs may be reaching different populations of IDUs and highlight a subpopulation of highly marginalized IDUs (i.e., black race, infrequent injectors) who are underusing safe syringe sources in NYC. Targeted interventions are needed to reduce racial disparities and increase use of safe syringe outlets.",
keywords = "Human immunodeficiency virus, Pharmacy services, Race, Syringe access, Syringe exchange programs",
author = "Rudolph, {Abby E.} and Crawford, {Natalie D.} and Ompad, {Danielle C.} and Benjamin, {Ebele O.} and Stern, {Rachel J.} and Fuller, {Crystal M.}",
year = "2010",
doi = "10.1331/JAPhA.2010.09193",
language = "English (US)",
volume = "50",
pages = "140--147",
journal = "Journal of the American Pharmacists Association : JAPhA",
issn = "1544-3191",
publisher = "American Pharmacists Association",
number = "2",

}

TY - JOUR

T1 - Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies

AU - Rudolph, Abby E.

AU - Crawford, Natalie D.

AU - Ompad, Danielle C.

AU - Benjamin, Ebele O.

AU - Stern, Rachel J.

AU - Fuller, Crystal M.

PY - 2010

Y1 - 2010

N2 - Objective: To describe injection drug users (IDUs) who access syringes through different outlets to help inform the prevention needs of IDUs who underuse safe syringe sources in New York City (NYC), where syringe availability is high compared with other U.S. cities. Design: Cross sectional. Setting: NYC, 2005-2007. Participants: 285 IDUs. Intervention: Participants were recruited using random street-intercept sampling in 36 socioeconomically disadvantaged neighborhoods. Main outcome measures: IDUs using syringe exchange programs (SEPs), pharmacies, or other outlets as a primary syringe source were compared based on sociodemographic characteristics, injection practices, and medical service use. Results: Chi-square tests and polytomous logistic regression were used to compare IDUs with different self-reported primary syringe sources used in the 6 months preceding study entry. Compared with IDUs using other syringe sources, those primarily using SEPs were less likely to be black (adjusted odds ratio 0.26 [95% CI 0.11-0.57]), more likely to inject daily (3.32 [1.58-6.98]), and more likely to inject with a new syringe (2.68 [1.30-5.54]). Compared with IDUs using other syringe sources, those primarily using pharmacies were less likely to be black (0.39 [0.17-0.90]). Conclusion: These data suggest that pharmacies and SEPs may be reaching different populations of IDUs and highlight a subpopulation of highly marginalized IDUs (i.e., black race, infrequent injectors) who are underusing safe syringe sources in NYC. Targeted interventions are needed to reduce racial disparities and increase use of safe syringe outlets.

AB - Objective: To describe injection drug users (IDUs) who access syringes through different outlets to help inform the prevention needs of IDUs who underuse safe syringe sources in New York City (NYC), where syringe availability is high compared with other U.S. cities. Design: Cross sectional. Setting: NYC, 2005-2007. Participants: 285 IDUs. Intervention: Participants were recruited using random street-intercept sampling in 36 socioeconomically disadvantaged neighborhoods. Main outcome measures: IDUs using syringe exchange programs (SEPs), pharmacies, or other outlets as a primary syringe source were compared based on sociodemographic characteristics, injection practices, and medical service use. Results: Chi-square tests and polytomous logistic regression were used to compare IDUs with different self-reported primary syringe sources used in the 6 months preceding study entry. Compared with IDUs using other syringe sources, those primarily using SEPs were less likely to be black (adjusted odds ratio 0.26 [95% CI 0.11-0.57]), more likely to inject daily (3.32 [1.58-6.98]), and more likely to inject with a new syringe (2.68 [1.30-5.54]). Compared with IDUs using other syringe sources, those primarily using pharmacies were less likely to be black (0.39 [0.17-0.90]). Conclusion: These data suggest that pharmacies and SEPs may be reaching different populations of IDUs and highlight a subpopulation of highly marginalized IDUs (i.e., black race, infrequent injectors) who are underusing safe syringe sources in NYC. Targeted interventions are needed to reduce racial disparities and increase use of safe syringe outlets.

KW - Human immunodeficiency virus

KW - Pharmacy services

KW - Race

KW - Syringe access

KW - Syringe exchange programs

UR - http://www.scopus.com/inward/record.url?scp=77952517172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952517172&partnerID=8YFLogxK

U2 - 10.1331/JAPhA.2010.09193

DO - 10.1331/JAPhA.2010.09193

M3 - Article

C2 - 20199954

AN - SCOPUS:77952517172

VL - 50

SP - 140

EP - 147

JO - Journal of the American Pharmacists Association : JAPhA

JF - Journal of the American Pharmacists Association : JAPhA

SN - 1544-3191

IS - 2

ER -